Trials / Active Not Recruiting
Active Not RecruitingNCT03255577
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer: A Prospective Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to help the investigators determine how accurate the sentinel lymph node biopsy (SLNB) procedure is in identifying residual cancer cells after neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sentinel Lymph Node Biopsy (SLNB) | Sentinel Lymph Node Biopsy Patients with locally advanced breast cancer will undergo SLNB with dual tracer mapping followed by completion axillary lymph node dissection. |
Timeline
- Start date
- 2017-08-17
- Primary completion
- 2026-06-15
- Completion
- 2026-08-30
- First posted
- 2017-08-21
- Last updated
- 2026-03-05
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03255577. Inclusion in this directory is not an endorsement.